The company recently filed a prospectus supplement with the U.S. Securities and Exchange Commission (SEC), under which it may offer and sell shares of its common stock having an aggregate offering value of up to $250 million from time to time through an at-the-market equity program. At the time Tilray said proceeds would help in leveraging anticipated regulatory changes in the U.S. cannabis sector among other things.